OrganOx
Generated by Meeveem AI
"Pioneering organ preservation technology that makes every donated organ count"
About OrganOx
OrganOx develops organ preservation technology for transplantation. Its OrganOx metra system uses normothermic machine perfusion to keep donor livers functioning outside the body, enabling clinicians to assess viability and plan surgery. Preservation is authorised for up to 24 hours in Europe and 12 hours in the US. By August 2026, the technology had supported over 10,000 liver transplants worldwide.
Founded in 2008 as a University of Oxford spinout, the Oxford-based company became part of Terumo in October 2025. It serves transplant centres internationally and is also developing kidney preservation technology, extending research beyond its established liver transplantation platform.
From engineering to clinical use
OrganOx connects development and engineering with clinical affairs, training and operational delivery. Clinical research teams feed technical and clinical experience back to engineers and train colleagues and research centres on devices and procedures. In the UK and Europe, operations teams coordinate components, spare parts and finished goods through warehouse and distribution partners. These functions support the development, supply and clinical use of the company’s organ technology.
199
Team Members
2008
Founded
Medical Devices
Sector
Hybrid
Work Environment